3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space

This hugely promising market, while witnessing rapid advancements, is still in the early stages of development and the prospects are majorly untapped. Companies with a strong presence in the ophthalmic market, such as Alcon Inc. (ALC) , Glaukos Corporation (GKOS) and Regeneron Pharmaceuticals, Inc. (REGN) , are well- positioned to leverage this prospect, making them promising investment opportunities. Cell therapy is emerging as a cutting-edge precision treatment in ophthalmology and is gaining immense popu ...